Abstract:Background Expression of neuronal elements has been identified in various glial tumors, and glioblastomas (GBMs) with neuronal differentiation patterns have reportedly been associated with longer survival. However, the neuronal class III β-tubulin has been linked to increasing malignancy in astrocytomas. Thus, the significance of neuronal markers in gliomas is not established. Methods The expressions of class III β-tubulin, neurofilament protein (NFP), microtubule-associated protein 2 (MAP2) and neuron-specific enolase (NSE) were investigated in five GBM cell lines and two GBM biopsies with immunocytochemistry and Western blot. Moreover, the expression levels were quantified by real-time qPCR under different culture conditions. Following NSE siRNA treatment we used Electric cell-substrate impedance sensing (ECIS) to monitor cell growth and migration and MTS assays to study viability after irradiation and temozolomide treatment. Finally, we quantitated NSE expression in a series of human glioma biopsies with immunohistochemistry using a morphometry software, and collected survival data for the corresponding patients. The biopsies were then grouped according to expression in two halves which were compared by survival analysis. Results Immunocytochemistry and Western blotting showed that all markers except NFP were expressed both in GBM cell lines and biopsies. Notably, qPCR demonstrated that NSE was upregulated in cellular stress conditions, such as serum-starvation and hypoxia, while we found no uniform pattern for the other markers. NSE knockdown reduced the migration of glioma cells, sensitized them to hypoxia, radio- and chemotherapy. Furthermore, we found that GBM patients in the group with the highest NSE expression lived significantly shorter than patients in the low-expression group. Conclusions Neuronal markers are aberrantly expressed in human GBMs, and NSE is consistently upregulated in different cellular stress conditions. Knockdown of NSE reduces the migration of GBM cells and sensitizes them to hypoxia, radiotherapy and chemotherapy. In addition, GBM patients with high NSE expression had significantly shorter survival than patients with low NSE expression. Collectively, these data suggest a role for NSE in the adaption to cellular stress, such as during treatment.

Different Nrf2 Expressions in Glioblastoma Cell Lines and Glioma Stem Cells from Xenografts

Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma.

Identification and Validation of SNHG Gene Signature to Predict Malignant Behaviors and Therapeutic Responses in Glioblastoma

Expression of Dedifferentiation Markers and Multilineage Markers in U251 Glioblastoma Cells with Silenced EGFR and FGFR Genes.

Knockdown of Nuclear Factor Erythroid 2-Related Factor 2 by Lentivirus Induces Differentiation of Glioma Stem-Like Cells.

Correction To: Nrf2 is Required to Maintain the Self-Renewal of Glioma Stem Cells

Knockdown of NF-E2-related Factor 2 Inhibits the Proliferation and Growth of U251MG Human Glioma Cells in a Mouse Xenograft Model

Correlation of Nrf2 and HIF-1α in Glioblastoma and Their Relationships to Clinicopathologic Features and Survival

A Novel Classifier Combining G Protein-Coupled Receptors and the Tumor Microenvironment is Associated with Survival Status in Glioblastoma.

The role of nuclear factor erythroid 2-related factor in cell proliferation of human glioma cell U251

Intrinsic Autofluorescent Phenotype: A Novel Biomarker to Identify and Isolate Glioma Stem-Like Cells

Expression of Nrf-2 and HO-1 and Their Significance in Human Glioblastoma

Analysis of Gene Expression Profiles in the Differentiation Process of Glioma Stem Cells to Endothelial Cells

The role of Nrf2 in migration and invasion of human glioma cell U251.

A Fast and Efficient Approach to Obtaining High-Purity Glioma Stem Cell Culture

The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells.

Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment

HMGA1 expression in glioma stem cells isolated from the glioblastoma multiforme cell line U251

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide

STEM-19. THE ISOLATION AND IDENTIFICATION OF GLIOMA STEM CELLS AND MESENCHYMAL STEM CELLS FROM HUMAN GLIOMA SPECIMENS

Co-expressions of Nanog gene, CD133 and GFAP in gliomas and their correlations